#CANCERSM Chat topic 14-Aug-2019–Finding Balance: “Cancer Life” vs. “Real Life”

In lieu of #LCSM Chat in August 2019, please join a collaborative #CancerSM chat with other cancer hashtag communities on Twitter (#gyncsm #bcsm #btsm #mmsm #ayacsm) about Finding Balance: ‘Cancer Life’ vs. ‘Real Life’.”  Note this is a different day and time than usual for #LCSM Chat–this chat will be Wednesday, August 14th at 9pm ET. Learn more at http://gyncsm.blogspot.com/2019/08/joint-cancersm-chat-finding-balance.html .  

#CANCERSM Chat topic 11-Jul-2019: Basics of Biomarker Testing

Until just a few years ago, chemotherapy was often the only option for some cancer patients.  In just a few short years, molecular therapies and immunotherapies have become commonplace as treatments for cancer patients.  But determining whether a particular cancer patient is a candidate for these new, often very expensive, molecular and immunotherapies requires molecular biomarker testing.  For many cancer patients and their families, the role of molecular biomarker testing in their diagnosis is a unfamiliar and confusing.  How is testing performed?  How is the test result analyzed? What is involved in… Read More

#LCSM Chat 2019/01/06–Immunotherapy: What Patients Need To Know

It’s a new year, and #LCSM Chat is transitioning to monthly chats.  Our first chat is a collaborative chat across all cancer hashtag communities titled “Immunotherapy: What Patients Need to Know.” The discussion will cover all types of immunotherapy currently approved for treatment of any cancer. Chat moderator Janet Freeman-Daily (@JFreemanDaily) will be joined by special guest Lisa Rezende (@LisaRezende1), a biology educator (Assistant Professor of Practice) on the Molecular and Cellular Biology faculty at the University of Arizona.  Lisa is also a long-term volunteer cancer advocate with FORCE (Facing Our Risk of… Read More